|
Real-time Estimate
Cboe BZX
15:59:50 2026-08-17 EDT
|
5-day change | 1st Jan Change | ||
| 1.190 USD | -3.25% |
|
-2.85% | -48.71% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.25% | -2.85% | -24.37% | -53.68% | -48.71% | -37.43% | -10.49% | -91.27% | - | 71.22M | |
| +4.80% | +7.80% | +31.41% | +61.82% | +84.12% | +70.64% | +114.21% | +22.28% | - | 70.07B | |
| +17.12% | +12.05% | +14.00% | +23.37% | +19.31% | +54.42% | +86.20% | +227.54% | +6,074.73% | 52.87B | |
| +3.69% | -5.03% | +18.14% | +19.43% | -26.47% | +0.55% | +482.48% | +448.76% | +951.52% | 27.02B | |
| +2.26% | +0.65% | +17.40% | +37.05% | +46.82% | +49.19% | +10.30% | -61.85% | - | 23.61B | |
| -1.62% | -0.87% | +0.56% | +3.53% | -3.37% | -18.27% | -18.75% | -74.88% | - | 23.38B | |
| -6.00% | +13.71% | +11.90% | +89.36% | +232.78% | +244.39% | +443.26% | +1,764.35% | +856.31% | 19.43B | |
| +3.80% | +5.25% | +11.29% | +24.94% | +3.80% | +40.50% | -16.41% | -28.12% | +88.53% | 18.75B | |
| +0.38% | -3.15% | 0.00% | +19.67% | +33.22% | +20.39% | +589.77% | - | - | 15.85B | |
| +2.13% | -1.27% | -6.49% | +4.92% | +19.30% | +38.48% | +149.00% | +175.21% | +392.37% | 12.7B | |
| +2.44% | -0.01% | +18.87% | +19.43% | +33.03% | +343.60% | +204.34% | +45.57% | +1,293.06% | 12.24B | |
| +3.63% | +1.51% | -5.48% | +0.17% | -10.17% | +33.65% | +200.66% | +536.04% | +5,777.98% | 11.73B | |
| -5.73% | -9.50% | -11.10% | -24.71% | -19.91% | -45.32% | +170.15% | +107.33% | - | 11.27B | |
| -4.31% | -14.89% | -8.36% | -21.00% | -27.64% | -51.86% | +603.12% | +75.05% | +81.50% | 10.65B | |
| +2.36% | -2.46% | -5.73% | +0.54% | +18.96% | +94.06% | +137.09% | +137.99% | +536.77% | 10.31B | |
| +1.01% | -0.84% | +4.20% | +49.03% | +218.80% | +516.53% | +775.81% | -35.93% | -29.19% | 9.14B | |
| +0.25% | -6.20% | -4.82% | -9.46% | +12.36% | +4.93% | +121.34% | -22.58% | - | 9.01B | |
| +0.08% | +0.71% | +1.06% | +144.22% | +82.05% | +184.95% | +422.79% | +285.73% | - | 8.98B | |
| +3.72% | +3.00% | +6.83% | +23.95% | +30.13% | +87.10% | +26.61% | +122.62% | - | 8.64B | |
| -0.30% | +2.61% | -3.27% | +30.04% | +15.26% | +31.23% | +428.35% | +331.49% | - | 8.03B | |
| Average | +1.21% | -2.00% | +3.30% | +22.13% | +35.68% | +83.09% | +245.99% | +208.70% | +1,602.36% | 18.19B | |
| Weighted average by Cap. | +3.70% | -1.36% | +11.39% | +31.55% | +43.39% | +73.76% | +206.75% | +214.17% | +2,488.23% |
- Stock Market
- Stocks
- SPRO Stock
- Sector Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
